The Vanderbilt group have just published the results of the feasibility trial MIND - Modifying the INcidence of Delirium in Critical Care Medicine. It is important because it was a placebo trial comparing ICU delirium duration using haloperidol, ziprasidone and placebo. While there was no difference between the groups it demonstrated safety and feasibility of such a study. The doors are open for a larger trial powered for meaningful outcomes.
News Archives
- February 2012
- January 2012
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- December 2008
- October 2008
- September 2008
- August 2008
